Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab – a case-based review
ARP Rheumatology · 2024
DOI: 10.63032/zvno7794 ↗Kurz gefasst
Fallbericht in der Zeitschrift ARP Rheumatology, 2024. Verfasst von Susana P Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal. Hauptthemen laut MEDLINE: Rituximab, Muscular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal.
- Unidade Local de Saúde de Santo António.
Zitieren
APA
Silva, S. P., Eugénio, G., Pinto, M., & Barcelos, A. (2024). Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab – a case-based review. ARP Rheumatology. https://doi.org/10.63032/zvno7794
Vancouver
Silva SP, Eugénio G, Pinto M, Barcelos A. Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab – a case-based review. ARP Rheumatology. 2024. doi:10.63032/zvno7794
BibTeX
@article{Silva2024,
author = {Silva, Susana P and Eugénio, Gisela and Pinto, Miguel and Barcelos, Anabela},
title = {Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab – a case-based review},
journal = {ARP Rheumatology},
year = {2024},
doi = {10.63032/zvno7794}
}
EUVIMED